Harold Morton Wolkin Sells 3,500 Shares of Cipher Pharmaceuticals Inc. (TSE:CPH) Stock

Cipher Pharmaceuticals Inc. (TSE:CPHGet Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the company’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00.

Cipher Pharmaceuticals Trading Down 3.3 %

Shares of TSE CPH traded down C$0.44 during midday trading on Monday, reaching C$12.70. The stock had a trading volume of 18,709 shares, compared to its average volume of 36,476. The firm has a market cap of C$228.01 million, a price-to-earnings ratio of 14.03 and a beta of 1.20. The company’s 50 day moving average price is C$12.91 and its 200 day moving average price is C$14.46. Cipher Pharmaceuticals Inc. has a twelve month low of C$7.90 and a twelve month high of C$19.69. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00.

Cipher Pharmaceuticals Company Profile

(Get Free Report)

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.

Recommended Stories

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.